State Street’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $15.3M | Buy |
820,137
+60,458
| +8% | +$1.13M | ﹤0.01% | 2333 |
|
2025
Q1 | $13.8M | Sell |
759,679
-59,164
| -7% | -$1.07M | ﹤0.01% | 2331 |
|
2024
Q4 | $17.9M | Sell |
818,843
-2,288
| -0.3% | -$49.9K | ﹤0.01% | 2282 |
|
2024
Q3 | $22.5M | Buy |
821,131
+413,425
| +101% | +$11.3M | ﹤0.01% | 2140 |
|
2024
Q2 | $10.6M | Buy |
407,706
+387,308
| +1,899% | +$10M | ﹤0.01% | 2531 |
|
2024
Q1 | $612K | Buy |
+20,398
| New | +$612K | ﹤0.01% | 3595 |
|
2023
Q3 | – | Sell |
-8,700
| Closed | -$106K | – | 4571 |
|
2023
Q2 | $106K | Hold |
8,700
| – | – | ﹤0.01% | 4226 |
|
2023
Q1 | $111K | Hold |
8,700
| – | – | ﹤0.01% | 4292 |
|
2022
Q4 | $55K | Hold |
8,700
| – | – | ﹤0.01% | 4539 |
|
2022
Q3 | $196K | Buy |
8,700
+781
| +10% | +$17.6K | ﹤0.01% | 4150 |
|
2022
Q2 | $152K | Sell |
7,919
-26,591
| -77% | -$510K | ﹤0.01% | 4332 |
|
2022
Q1 | $1.6M | Sell |
34,510
-1,595
| -4% | -$74K | ﹤0.01% | 3651 |
|
2021
Q4 | $2.56M | Buy |
36,105
+2,575
| +8% | +$183K | ﹤0.01% | 3566 |
|
2021
Q3 | $3.91M | Buy |
33,530
+4,815
| +17% | +$561K | ﹤0.01% | 3356 |
|
2021
Q2 | $4.49M | Buy |
28,715
+6,090
| +27% | +$953K | ﹤0.01% | 3300 |
|
2021
Q1 | $4.29M | Buy |
22,625
+96
| +0.4% | +$18.2K | ﹤0.01% | 3113 |
|
2020
Q4 | $2.83M | Buy |
22,529
+369
| +2% | +$46.3K | ﹤0.01% | 3226 |
|
2020
Q3 | $2.41M | Sell |
22,160
-471
| -2% | -$51.2K | ﹤0.01% | 3119 |
|
2020
Q2 | $2.72M | Buy |
22,631
+508
| +2% | +$61K | ﹤0.01% | 3058 |
|
2020
Q1 | $2.22M | Sell |
22,123
-597
| -3% | -$60K | ﹤0.01% | 3019 |
|
2019
Q4 | $5.51M | Buy |
22,720
+1,961
| +9% | +$476K | ﹤0.01% | 2804 |
|
2019
Q3 | $3.41M | Buy |
20,759
+3,464
| +20% | +$569K | ﹤0.01% | 2982 |
|
2019
Q2 | $4.08M | Buy |
17,295
+7,777
| +82% | +$1.84M | ﹤0.01% | 2937 |
|
2019
Q1 | $2.51M | Buy |
9,518
+8,112
| +577% | +$2.14M | ﹤0.01% | 3060 |
|
2018
Q4 | $128K | Buy |
+1,406
| New | +$128K | ﹤0.01% | 3616 |
|